Nicotine Lozenges in the Relief of Behaviorally Provoked Craving
Bibliographic Data
| ID | 15329482 |
|---|---|
| Authors | Mitchell Nides (Los Angeles Clinical Trials, Burbank, CA, USA. [email protected], corresponding author), Gilbert Shanga (GlaxoSmithKline (United States)), Gilbert Marava Shanga (Biostatistics, Research and Development, GlaxoSmithKline Consumer Healthcare, Warren, NJ, USA), Amanda Bishop (Respiratory Health, Clinical Development Medical Affairs, Research and Development, GlaxoSmithKline Consumer Healthcare, Warren, NJ, USA), Amanda J Bishop (GlaxoSmithKline (United States)), William D Becker (Medical Affairs, GlaxoSmithKline Consumer Healthcare, Warren, NJ, USA) |
| Year | 2018 |
| Volume | 42 |
| Issue | 3 |
| Pages | 69-80 |
| Publication date | 2018-04-17 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Health Behavior (JOURNAL) |
| Journal identifiers | ISSN: 1087-3244 • E-ISSN: 1945-7359 |
| Publisher | PNG Publications (PUBLISHER • US) |
| DOI | 10.5993/ajhb.42.3.7 |
| PMID | 29663982 |
| OpenAlex | W2800222583 |
| Language | EN |
Behaviorally provoked nicotine craving can be significantly and safely reduced in heavy/high-dependency smokers with 4-mg nicotine mini lozenges
Abstinence · Addiction · Anesthesia · Confidence interval · Craving · Lozenge · Nicotine · Nicotine patch · Nicotine replacement therapy · Nicotine withdrawal · Placebo · Provocation test · Psychiatry · Smoking cessation · Behavioral Health and Interventions · Media Influence and Health · Medicine · Smoking Behavior and Cessation · Internal Medicine
| Citation velocity | historical |
|---|---|
| Highly cited | No |